U.S. flag

An official website of the United States government

NM_004004.6(GJB2):c.407dup (p.Tyr136Ter) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 6, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001870431.3

Allele description [Variation Report for NM_004004.6(GJB2):c.407dup (p.Tyr136Ter)]

NM_004004.6(GJB2):c.407dup (p.Tyr136Ter)

Gene:
GJB2:gap junction protein beta 2 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
13q12.11
Genomic location:
Preferred name:
NM_004004.6(GJB2):c.407dup (p.Tyr136Ter)
HGVS:
  • NC_000013.11:g.20189175dup
  • NG_008358.1:g.8801dup
  • NM_004004.6:c.407dupMANE SELECT
  • NP_003995.2:p.Tyr136Ter
  • LRG_1350t1:c.407dup
  • LRG_1350:g.8801dup
  • LRG_1350p1:p.Tyr136Ter
  • NC_000013.10:g.20763313_20763314insT
  • NC_000013.10:g.20763314dup
Protein change:
Y136*
Links:
dbSNP: rs771409330
NCBI 1000 Genomes Browser:
rs771409330
Molecular consequence:
  • NM_004004.6:c.407dup - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002120363Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 6, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Spectrum of GJB2 gene variants in Indian children with non-syndromic hearing loss.

Singh PK, Sharma S, Ghosh M, Shastri SS, Gupta N, Kabra M.

Indian J Med Res. 2018 Jun;147(6):615-618. doi: 10.4103/ijmr.IJMR_76_16. No abstract available.

PubMed [citation]
PMID:
30168495
PMCID:
PMC6118150

Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss.

Kelley PM, Harris DJ, Comer BC, Askew JW, Fowler T, Smith SD, Kimberling WJ.

Am J Hum Genet. 1998 Apr;62(4):792-9.

PubMed [citation]
PMID:
9529365
PMCID:
PMC1377046
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV002120363.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change creates a premature translational stop signal (p.Tyr136*) in the GJB2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 91 amino acid(s) of the GJB2 protein. This variant is present in population databases (rs771409330, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with non-syndromic hearing loss (PMID: 30168495). ClinVar contains an entry for this variant (Variation ID: 1357104). This variant disrupts a region of the GJB2 protein in which other variant(s) (p.Cys211Leufs*5) have been determined to be pathogenic (PMID: 9529365, 12910486, 20863150). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 28, 2024